News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Phase 2 study OptiTROP-Lung01 had promising results in patients with advanced NSCLC – LUNGevity Foundation
Photo from LUNGevity Foundation/X
Jun 1, 2024, 11:46

Phase 2 study OptiTROP-Lung01 had promising results in patients with advanced NSCLC – LUNGevity Foundation

LUNGevity Foundation shared on X/Twitter:

“Phase 2 study (OptiTROP-Lung01) had promising results in patients with advanced NSCLC . Phase 3 study versus immunotherapy is underway. More ADC studies are needed.”

Image

Source: LUNGevity Foundation/X

ADC advanced NSCLC cancer immunotherapy LUNGevity Foundation OncoDaily Oncology OptiTROP-Lung01 phase 2 study Phase 3
Special Coverage
Opinion
Nov 13, 2024, 17:14
Share your experiences of life with a kidney cancer diagnosis - Action Kidney Cancer
Blog
Nov 13, 2024, 16:51
The 11th edition of Richi Entrepreneurs has officially kicked off
Blog
Nov 13, 2024, 16:49
Dégi László Csaba: Transforming Cancer Care Together
Blog
Nov 13, 2024, 16:45
Jun Gong: The best awards are patient awards
Blog
Nov 13, 2024, 16:39
Bami Adenipekun: How being impacted by breast cancer for over 3 decades shapes the work that I do
Insight
Nov 13, 2024, 16:25
A clear picture of the ground reality
Insight
Nov 13, 2024, 16:23
Make your mark in Oncology research with JCO Oncology Advances - ASCO
Blog
Nov 13, 2024, 16:08
Evolving role of Radiation in early stage NSCLC by Dr. Annalisa Nardone
Insight
Nov 13, 2024, 16:02
Exploring New Avenues in Breast Cancer Treatment - The Babak Lab
Insight
Nov 13, 2024, 16:00
Role of antibody drug conjugates in the treatment of patients with breast cancer brain metastases
Blog
Nov 13, 2024, 15:56
Awareness campaigns have helped Increase Lung Cancer Screening Rates - IASLC
Blog
Nov 13, 2024, 15:56
Jennifer Ivanovich: Thrilled to see the announcement of the new ESMO Rare Cancers journal